Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE ·
6ix hasn’t read this filing yet.
Shanghai InnoStar Bio-tech Co. Ltd. on 6ix
Earlier from Shanghai InnoStar Bio-tech
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Proposed Business Adjustment of Holding Subsidiary
- Announcement on Resolutions of the 2024 Annual General Meeting
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
- Notice on Convening the 2024 Annual General Meeting
Later from Shanghai InnoStar Bio-tech
- Announcement on Lifting of Trading Restrictions for Pre-IPO Issued Shares and Strategic Placement Shares from the Initial Public Offering
- Announcement on Purchasing Liability Insurance for Directors, Supervisors, and Senior Management Members
- Announcement on Change of Company Website and Investor Address
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Report for Q3 2025
Follow Shanghai InnoStar Bio-tech into a list and get an email when it puts out news.
Follow Shanghai InnoStar Bio-tech